Crinetics Pharmaceuticals Inc (NASDAQ:CRNX)
| 18.94 Delayed Data As of 4:00pm ET |  +1.96 / +11.54%Today’s Change | 11.61 Today|||52-Week Range 23.70 | +34.23% Year-to-Date |
Latest CRNX News | Press Releases
No recent news for Crinetics Pharmaceuticals Inc.
Today’s Trading
| Previous close | 16.98 |
| Today’s open | 17.05 |
| Day’s range | 17.02 - 18.96 |
| Volume | 8,434 |
| Average volume (3 months) | 135,264 |
| Market cap | $638.3M |
Data as of 4:00pm ET, 06/14/2021
Growth & Valuation
| Earnings growth (last year) | -16.23% |
| Earnings growth (this year) | -8.35% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 3.32 |
Competitors
| ---- | ||
| ESPREsperion Therapeutic... | -0.59 | -2.24% |
| GOSSGossamer Bio Inc | -0.02 | -0.23% |
| ORTXOrchard Therapeutics... | -0.07 | -1.37% |
Data as of 3:59pm ET, 06/14/2021
Financials
| Next reporting date | August 17, 2021 |
| EPS forecast (this quarter) | -$0.61 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$73.8M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
